Relation of locus 1p13 rs646776 polymorphism with the risk of preeclampsia

References

• Ray JG, Vermeulen MJ, Schull MJ,  Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797–803. doi:10.1016/S0140-6736(05)67726-4.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–94. doi:10.1126/science.1111726.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Karumanchi SA. Angiogenic factors a preeclampsia. Semin Nephrol. 2011;31:33–46. doi:10.1016/j.semnephrol.2010.10.004.
   PubMed Web of Science ®Google Scholar
• Naljayan MV, Karumanchi SA. New developments in the pathogenesis of preeclampsia. Adv Chronic Kidney Dis. 2013;20:265–70. doi:10.1053/j.ackd.2013.02.003.
   PubMed Web of Science ®Google Scholar
• Agarwal I, Karumanchi SA. Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens. 2011;1:17–21. doi:10.1016/j.preghy.2010.10.007.
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Jaleel A, Tamimi W,  Al Kadri HM. Role of oxidative stress in the pathogenesis of preeclampsia. Arch Gynecol Obstet. 2010;282:469–74. doi:10.1007/s00404-010-1538-6.
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173–92. doi:10.1146/annurev-pathol-121808-102149.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009;24:147–58.
   PubMed Web of Science ®Google Scholar
• Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, Correa P, Repetto GM, Illanes SE. Pathogenesis of preeclampsia: the genetic component. J Pregnancy. 2012;2012:632732. doi:10.1155/2012/632732.
   PubMedGoogle Scholar
• Hubáček JA, Adámková V, Lánská V, Dlouhá D, Rynekrová J, Zlatohlávek L, et al. Variant within CELSR2/PSRC1/SORT1 but not within CILP2/PBAX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy. J App Biomed. 2012;10:19–28. doi:10.2478/v10136-012-0001-3.
   Web of Science ®Google Scholar
• Zhong LY, Cayabyab FS, Tang CK,  Zheng XL, Peng TH, Lv YC. Sortilin: A novel regulator in lipid metabolism and atherogenesis. Clin Chim Acta. 2016;460:11–17. doi:10.1016/j.cca.2016.06.013.
   PubMed Web of Science ®Google Scholar
• Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician. 2004;70:2317–24.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Grotegut CA. Prevention of preeclampsia. J Clin Invest. 2016;126:4396–98. doi:10.1172/JCI91300.
   PubMed Web of Science ®Google Scholar
• Sharma S, Bhaskaran S, Tripathi SB, Vaid N, Varma B. Polymorphisms in renin-angiotensin-aldosterone system and vascular endothelial growth factor may cross talk in preeclampsia: a pilot study of maternal and fetal dyads in Indian population. Int J Res Med Sci. 2016;4:1666–72. doi:10.18203/2320-6012.ijrms20161246.
   Google Scholar
• Enaruna NO, Idemudia JO, Aikoriogie PI. Serum lipid profile and uric acid levels in preeclampsia in University of Benin Teaching Hospital. Niger Med J. 2014;55:423–27. doi:10.4103/0300-1652.140387.
   PubMedGoogle Scholar
• Siddiqui IA. Maternal serum lipids in women with pre-eclampsia. Ann Med Health Sci Res. 2014;4:638–41. doi:10.4103/2141-9248.139358.
   PubMedGoogle Scholar
• Arvind P, Nair J, Jambunathan S,  Kakkar VV, Shanker J. CELSR2-PSRC1-SORT1 gene expression and association with coronary artery disease and plasma lipid levels in an Asian Indian cohort. J Cardiol. 2014;64:339–46. doi:10.1016/j.jjcc.2014.02.012.
   PubMedGoogle Scholar
• Muendlein A, Geller-Rhomberg S, Saely CH,  Winder T, Sonderegger G, Rein P, et al. Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis. Atherosclerosis. 2009;206:494–99. doi:10.1016/j.atherosclerosis.2009.02.040.
   PubMed Web of Science ®Google Scholar
• Oh TJ, Ahn CH, Kim BR, Kim KM, Moon JH, Lim S, et al. Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus. Cardiovasc Diabetol. 2017;16:92. doi:10.1186/s12933-017-0568-9.
   PubMed Web of Science ®Google Scholar
• Goettsch C, Iwata H, Hutcheson JD,  O'Donnell CJ, Chapurlat R, Cook NR, et al. Serum sortilin associates with aortic calcification and cardiovascular risk in men. Arterioscler Thromb Vasc Biol. 2017;37:1005–11. doi:10.1161/ATVBAHA.116.308932.
   PubMed Web of Science ®Google Scholar
• Ogawa K, Ueno T, Iwasaki T, Kujiraoka T, Ishihara M, Kunimoto S, et al. Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors. Atherosclerosis. 2016;249:110–15. doi:10.1016/j.atherosclerosis.2016.03.041.
   PubMed Web of Science ®Google Scholar
• Bikulowa K, Borschewksi A, Dathe C, Willnow TE, Bachmann S, Mutig K. Renal phenotype of sortilin-deficient mice. FASEB J. 2014;28(1):892.41.
   Google Scholar
• Prabakaran T, Nielsen R, Satchell SC, Mathieson PW, Feldt-Rasmussen U, Sørensen SS, et al. Mannose 6-phosphate receptor and sortilin mediated endocytosis of α-galactosidase A in kidney endothelial cells. PLoS One. 2012;7(6):e39975. doi:10.1371/journal.pone.0039975.
   PubMed Web of Science ®Google Scholar
• Rizk NM, El-Menyar A, Egue H, Wais IS, Baluli HM, Alali K, et al. The association between serum LDL cholesterol and genetic variation in chromosomal locus 1p13.3 among coronary artery disease patients. Biomed Res Int. 2015;2015:678924. doi:10.1155/2015/678924.
   PubMedGoogle Scholar
• Gigante B, Leander K, Vikström M,  Ye S, de Faire U. Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels. BMC Cardiovasc Disord. 2012;12:90. doi:10.1186/1471-2261-12-90.
   PubMed Web of Science ®Google Scholar
• Carrasquillo MM, Nicholson AM, Finch N, Gibbs JR, Baker M, Rutherford NJ, et al. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Am J Hum Genet. 2010;87:890–97. doi:10.1016/j.ajhg.2010.11.002.
   PubMed Web of Science ®Google Scholar
• Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J, Petersen CM. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999;274:8832–36. doi:10.1074/jbc.274.13.8832.
   PubMed Web of Science ®Google Scholar
• Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189–97. doi:10.1038/ng.75.
   PubMed Web of Science ®Google Scholar
• Fiore G, Florio P, Micheli L,  Nencini C, Rossi M, Cerretani D, et al. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab. 2005;90:4205–10. doi:10.1210/jc.2004-1632.
   PubMed Web of Science ®Google Scholar
• Struck J, Morgenthaler NG, Bergmann A. Proteolytic processing pattern of the endothelin-1 precursor in vivo. Peptides. 2005;26:2482–86. doi:10.1016/j.peptides.2005.05.010.
   PubMed Web of Science ®Google Scholar
• Jain A. Endothelin-1: a key pathological factor in pre-eclampsia? Reprod Biomed Online. 2012;25:443–49. doi:10.1016/j.rbmo.2012.07.014.
   PubMed Web of Science ®Google Scholar